Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone.
Ma HY, Vander Heiden JA, Uttarwar S, Xi Y, N'Diaye EN, LaCanna R, Caplazi P, Gierke S, Moffat J, Wolters PJ, Ding N.
Ma HY, et al. Among authors: xi y.
Eur Respir J. 2023 Apr 27;61(4):2200604. doi: 10.1183/13993003.00604-2022. Print 2023 Apr.
Eur Respir J. 2023.
PMID: 36585256
Free PMC article.